Factor XI apple domains and protein dimerization

被引:33
作者
Cheng, Q
Sun, MF
Kravtsov, DV
Aktimur, A
Gailani, D
机构
[1] Vanderbilt Univ, Div Hematol Oncol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA
关键词
apple domain; dimer; factor XI; prekallikrein;
D O I
10.1046/j.1538-7836.2003.00418.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The coagulation protease zymogen factor (F)XI is a disulfide bond-linked homodimer, a configuration that is necessary for protein secretion and function. The non-catalytic portion of the FXI polypeptide contains four repeats called apple domains (A1-A4). It is clear that FXI A4 plays a key role in dimer formation, however, the importance of other apple domains to this process has not been examined. We prepared recombinant FXI molecules in which apple domains were exchanged with those of the structurally homologous monomeric protein prekallikrein (PK). As expected, FXI/PK chimeras containing FXI A4 are dimers, while those with PK A4 are monomers. FXI A4 contains cysteine at position 321 that forms the interchain disulfide bond, while Cys321 in PK is unavailable for interchain bond formation because it is paired with Cys326. FXI/PK chimeras containing PK A4 were modified by changing Cys326 to glycine, leaving Cys321 unpaired (PKA4-Gly326). FXI with a PK A4 domain is a monomer, however, introducing PKA4-Gly326 results in a disulfide bond-linked dimer. This indicates that dimer formation can occur in the absence of FXI A4. In proteins containing PKA4-Gly326, replacing FXI A3 with PK A3 partially interferes with dimer formation, while substitution of A2, or A2 and A3 prevents dimer formation. PKA4-Gly326 cannot induce the native PK molecule to dimerize. The data indicate that FXI A2 and A3 make contributions to dimer formation. As these domains are involved in activities that require dimeric protein, it seems reasonable that they stabilize this conformation.
引用
收藏
页码:2340 / 2347
页数:8
相关论文
共 30 条
[1]   FACTOR-XI (PLASMA THROMBOPLASTIN ANTECEDENT) DEFICIENCY IN ASHKENAZI JEWS IS A BLEEDING DISORDER THAT CAN RESULT FROM 3 TYPES OF POINT MUTATIONS - (COAGULATION GENETIC-DEFECT POLYMERASE CHAIN-REACTION) [J].
ASAKAI, R ;
CHUNG, DW ;
RATNOFF, OD ;
DAVIE, EW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :7667-7671
[2]   FACTOR-XI DEFICIENCY IN ASHKENAZI JEWS IN ISRAEL [J].
ASAKAI, R ;
CHUNG, DW ;
DAVIE, EW ;
SELIGSOHN, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03) :153-158
[3]   RETRACTED: Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa (Retracted article. see vol 282, pg 29067, 2007) [J].
Baglia, FA ;
Walsh, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (27) :20514-20519
[4]   A binding site for the kringle II domain of prothrombin in the Apple 1 domain of factor XI [J].
Baglia, FA ;
Badellino, KO ;
Ho, DH ;
Dasari, VR ;
Walsh, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (41) :31954-31962
[5]  
BAGLIA FA, 1991, J BIOL CHEM, V266, P24190
[6]   RETRACTED: Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin (Retracted Article. See vol 282, pg 29067, 2007) [J].
Baglia, FA ;
Badellino, KO ;
Li, CQ ;
López, JA ;
Walsh, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (03) :1662-1668
[7]  
Baglia FA, 1996, J BIOL CHEM, V271, P3652
[8]  
BOUMA BN, 1977, J BIOL CHEM, V252, P6432
[9]   HUMAN-PLASMA PREKALLIKREIN, A ZYMOGEN TO A SERINE PROTEASE THAT CONTAINS 4 TANDEM REPEATS [J].
CHUNG, DW ;
FUJIKAWA, K ;
MCMULLEN, BA ;
DAVIE, EW .
BIOCHEMISTRY, 1986, 25 (09) :2410-2417
[10]   Contact system: A vascular biology modulator with anticoagulant, Profibrinolytic, antiadhesive, and proinflammatory attributes [J].
Colman, RW ;
Schmaier, AH .
BLOOD, 1997, 90 (10) :3819-3843